Skip to main content
Clinical Trials/TCTR20200105005
TCTR20200105005
Completed
未知

se of simplified HAS-BLED score for predicting bleeding events in anticoagulated patients with atrial fibrillation

o0 sites110 target enrollmentJanuary 5, 2020

Overview

Phase
未知
Intervention
Not specified
Conditions
AF patients receiving warfarin at Central Chest Institute of Thailand.
Sponsor
o
Enrollment
110
Status
Completed
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
January 5, 2020
End Date
April 13, 2020
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Sponsor
o

Eligibility Criteria

Inclusion Criteria

  • AF patients who were received warfarin.

Exclusion Criteria

  • 1\. Contraindication of warfarin or warfarin use less than 1 year
  • 2\. Each INR level was checked more than 6 months
  • 3\. All types of prosthetic heart valve including mitral valve repair
  • 4\. Patients with thrombocytopenia, myeloproliferative disorders (essential thrombocythemia, chronic myeloid leukemia, polycythemia vera, agnogenic myeloid metaplasia), hyperviscosity syndrome or cirrhosis
  • 5\. Pregnancy
  • 6\. Patients participating in other concealed study
  • 7\. Warfarin interruption from surgery or invasive procedure during study
  • 8\. Hospitalization during study
  • 9\. Warfarin discontinuation during study

Outcomes

Primary Outcomes

Not specified

Similar Trials